Psychemedics Stock Today
| PMD Stock | USD 1.85 0.76 29.12% |
Performance0 of 100
| Odds Of DistressLess than 15
|
Psychemedics is trading at 1.85 as of the 20th of December 2024, a 29.12% down since the beginning of the trading day. The stock's lowest day price was 1.85. Psychemedics has less than a 15 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 21st of September 2024 and ending today, the 20th of December 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 17th of February 1994 | Category Healthcare | Classification Health Care |
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts. The company has 5.89 M outstanding shares of which 38.6 K shares are at this time shorted by investors with about 0.79 days to cover. More on Psychemedics
Moving against Psychemedics Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Psychemedics Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | Brian Hullinger |
| Thematic Idea | Healthcare (View all Themes) |
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Healthcare, Health Care, Health Care Providers & Services, Diagnostics & Research, Healthcare (View all Sectors) |
Psychemedics (PMD) is traded on NASDAQ Exchange in USA. It is located in 5220 Spring Valley Road, Dallas, TX, United States, 75254 and employs 116 people. Psychemedics is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a total capitalization of 15.74 M. Psychemedics runs under Health Care Providers & Services sector within Health Care industry. The entity has 5.89 M outstanding shares of which 38.6 K shares are at this time shorted by investors with about 0.79 days to cover.
Psychemedics has about 1.79 M in cash with (1.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32.
Check Psychemedics Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Psychemedics is $15.74 Million. Psychemedics has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Psychemedics Ownership Details
Psychemedics Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Northern Trust Corp | 2024-09-30 | 18.9 K | |
| Morgan Stanley - Brokerage Accounts | 2024-09-30 | 3 K | |
| Tower Research Capital Llc | 2024-09-30 | 2 K | |
| Advisor Group Holdings, Inc. | 2024-09-30 | 257 | |
| Caldwell Sutter Capital Inc | 2024-09-30 | 250 | |
| Fmr Inc | 2024-09-30 | 100.0 | |
| Bank Of America Corp | 2024-09-30 | 51.0 | |
| Royal Bank Of Canada | 2024-06-30 | 50.0 | |
| Jpmorgan Chase & Co | 2024-09-30 | 11.0 | |
| 22nw, Lp | 2024-09-30 | 276 K | |
| Renaissance Technologies Corp | 2024-09-30 | 270.9 K |
Psychemedics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Psychemedics market risk premium is the additional return an investor will receive from holding Psychemedics long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.063 | |||
| Jensen Alpha | 0.3603 | |||
| Total Risk Alpha | 0.1983 | |||
| Sortino Ratio | 0.0681 |
Psychemedics Stock Against Markets
Psychemedics Corporate Management
| Michael Schaffer | VP of Laboratory Operations | Profile | |
| Michael Weisenhoff | Principal Manager | Profile | |
| Charles IV | Ex VP | Profile | |
| Shannon Shoemaker | Chief Officer | Profile | |
| Werner Baumgartner | Founder | Profile | |
| Annette Baumgartner | Founder | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Psychemedics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Psychemedics Stock refer to our How to Trade Psychemedics Stock guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Psychemedics. If investors know Psychemedics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Psychemedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Earnings Share (0.51) | Revenue Per Share 3.586 | Quarterly Revenue Growth (0.15) | Return On Assets (0.16) |
The market value of Psychemedics is measured differently than its book value, which is the value of Psychemedics that is recorded on the company's balance sheet. Investors also form their own opinion of Psychemedics' value that differs from its market value or its book value, called intrinsic value, which is Psychemedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psychemedics' market value can be influenced by many factors that don't directly affect Psychemedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Psychemedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Psychemedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psychemedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.